Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06156046

Tolerance in Beekeepers

Beekeepers experience multiple bee stings each year. Many of these beekeepers (25-60%) become sensitized to bee venom through the production of specific antibodies that target the bee venom. Although these antibodies are important in the triggering of an allergic reaction only a small number of sensitised beekeepers go on to have an allergic reaction with symptoms away from the site of the sting. These reactions can be severe and are known as anaphylactic reactions.

The study investigates why some beekeepers develop severe allergic symptoms after bee stings while others do not.

This study will explore factors in the blood that protect sensitised individuals from having anaphylactic reactions - meaning that despite being sensitised they are tolerant and do not react to subsequent stings.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Derriford Hospital - University Hospitals Plymouth

Plymouth, Devon, PL65FP, United Kingdom

Location status: Recruiting

Location contact

Claire Bethune

PRINCIPAL_INVESTIGATOR

Jane Evely

CONTACT

[email protected]

+44 01752 431816

About this study

Beekeepers experience multiple stings each year many of whom (25-60%) become sensitised to bee (apis mellifera) venom through the production of IgE antibodies. However only a small proportion of the sensitised group go on to have anaphylaxis to bee venom. This study will investigate differences in T cell tolerance to bee venom in 3 groups by exploring factors that "protect" sensitised individuals from having anaphylactic reactions - meaning that despite being sensitised they are tolerant and do not react to subsequent stings.

T regulatory cell (Tregs) play a critical role in promoting immune tolerance to allergens and Treg generation has been shown to occur in bee venom allergic individuals following venom desensitisation therapy. Observations in sensitised tolerant (non-allergic) beekeepers (TB) suggest that exposure to venom through bee stings results in a similar increase in the frequencies of induced Tregs (iTregs). Helios negative induced Treg cells have also been suggested to contribute significantly to the establishment of immune tolerance in beekeepers. We will analyse the differences in Treg and Teffector (Teff) populations comparing sensitised beekeepers who are able to tolerate venom exposure (sensitised, tolerant beekeepers TB) with those beekeepers who do develop symptoms of systemic allergic reactions following bee sting (AB). A group of non-sensitised (NS) individuals will be recruited as a control population. We will perform RNA-seq to analyse the gene expression in Treg cells and Teff cells from all three groups. This will help to identify molecular targets that are involved in inducing the allergic reaction and also the genes that are involved in suppressing this reaction.

Considering the outcome of tolerance or anaphylaxis following bee stings, and the role of Treg and Teff cells in these processes, we will investigate the epigenetic regulations involved, which determine these cell's function. RNA-seq analysis will provide critical information about the genes involved in allergic reaction or in its suppression. DNA and histone modification analyses in the regulatory regions of these genes will help to better understand the underlying mechanism.

This project will investigate why some beekeepers who are sensitised to bee venom are able to tolerate bee stings, while in other sensitised individuals a bee sting can lead to life threatening anaphylaxis. This is not only of significance to beekeepers, but also has potential implications for the understanding of allergen tolerance in other allergic disease.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Group 1 inclusion criteria.
  • Individuals naive to beekeeping (<2 previous bee stings, none in the last 24 months)
  • no history of anaphylaxis to stings. Group 2 inclusion criteria.
  • Beekeepers with > approximately 10 stings/year who have been beekeeping for >3 years.
  • No history of anaphylaxis to bee venom. Group 3 inclusion criteria
  • Beekeepers with diagnosis of anaphylaxis to bee venom in the last 12 months who are sensitised to bee venom (as evidenced by positive specific IgE and positive skin test to bee venom)

Exclusion criteria

  • Unable to understand protocol/consent.
  • Unable to commit to follow up visits.
  • Participants with a known history of mastocytosis or under investigation for suspected mastocytosis.
  • Participants undergoing desensitisation treatment to bee venom before the first visit.
  • Participants being treatment with immunosuppressive medications. being treatment with immunosuppressive medications.

Treatment and study plan

Skin prick test

Diagnostic Test

Skin prick test for bee venom

Blood tests

Diagnostic Test

IgE/G and T cell tolerance studies

Primary outcomes

  1. Cell comparison

    Time frame: 3 years

    (i) To compare the number of various cell (CD4+, CD8+ and Treg etc.) populations in the non-sensitised control population (NS), the sensitised but tolerant beekeepers (TB) and the allergic beekeeper (AB) population.

  2. Cellular function

    Time frame: 3 years

    (ii) To identify differences in cellular function in the non-sensitised control population (NS), the sensitised but tolerant beekeepers (TB) and the allergic beekeeper (AB) population.

  3. Molecular mechanism

    Time frame: 3 years

    (iii) To elucidate the molecular mechanism and the differences observed in (i) and (ii).

  4. Epi regulation

    Time frame: 3 years

    (iiii) To elucidate the epigenetic regulation underpinning and the differences observed in (i) and (ii)

Secondary outcomes

  1. Sensitisation data- skin prick testing

    Time frame: 3 years

    To compare results of skin prick testing from the beginning and end of the beekeeping season.

  2. Sensitisation data - specific IgE's in blood

    Time frame: 3 years

    To compare results of specific IgE's in blood from the beginning and end of the beekeeping season.

Study contacts

Contact information is provided by the study sponsor or research team.

Jane Evely

CONTACT

[email protected]

441752431816

Sponsors and collaborators

Lead sponsor

University Hospital Plymouth NHS Trust

Other

Collaborators

  • University of Plymouth

Registry information

Official study title

Elucidation of the Mechanism of Immune Tolerance in Beekeepers

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Dec 5, 2023
Registry last updated
Apr 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.